25
Aug
Mumbai (Maharashtra) [India], August 25: Anlon Healthcare Limited (The Company, Anlon) is a chemical manufacturing company engaged in producing high purity advanced pharmaceutical intermediates, proposes to open its Initial Public Offering on Aug 26, 2025, aiming to raise ₹ 121.03Crores (at upper price band) with shares to be listed on the NSE & BSE. The issue size is 1,33,00,000 equity shares with a face value of ₹ 10 each with a price band of ₹ 86 – ₹ 91 Per Share. Equity Share Allocation • Qualified Institutional Buyer – 75% of the offer • Non-Institutional Investor – 15% of the offer • Individual Investor – 10% of the offer The net proceeds from the IPO will be utilized for Funding capital expenditure requirements for our Manufacturing Facility, Full or part…
